The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-((3-((Cyclopropylmethyl)carbamoyl)-2-methoxyphenyl)-amino)-6-((5-fluoro-4-methyl-pyridin-2-yl)amino)-N-methylnicotinamide ID: ALA4527672
PubChem CID: 155544232
Max Phase: Preclinical
Molecular Formula: C25H27FN6O3
Molecular Weight: 478.53
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CNC(=O)c1cnc(Nc2cc(C)c(F)cn2)cc1Nc1cccc(C(=O)NCC2CC2)c1OC
Standard InChI: InChI=1S/C25H27FN6O3/c1-14-9-21(29-13-18(14)26)32-22-10-20(17(12-28-22)24(33)27-2)31-19-6-4-5-16(23(19)35-3)25(34)30-11-15-7-8-15/h4-6,9-10,12-13,15H,7-8,11H2,1-3H3,(H,27,33)(H,30,34)(H2,28,29,31,32)
Standard InChI Key: FXNUIYODKGAABX-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 38 0 0 0 0 0 0 0 0999 V2000
4.6458 -15.2748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6447 -16.0944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3527 -16.5033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0624 -16.0939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0596 -15.2712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3510 -14.8660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7708 -16.5014 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4778 -16.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1828 -16.4996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8894 -16.0906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8886 -15.2725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1753 -14.8652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4716 -15.2766 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5951 -14.8619 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.3485 -14.0488 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9380 -14.8664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9378 -14.0492 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2304 -15.2752 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5226 -14.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0550 -13.6381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7618 -14.0469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4678 -13.6369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4658 -12.8188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7519 -12.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0488 -12.8249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3382 -12.4214 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6335 -12.8351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5976 -16.4984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7466 -11.5954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4516 -11.1822 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0362 -11.1914 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1620 -11.5862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8670 -11.1730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6823 -11.1670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2691 -10.4620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
11 14 1 0
6 15 1 0
1 16 1 0
16 17 2 0
16 18 1 0
18 19 1 0
15 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
25 26 1 0
26 27 1 0
10 28 1 0
24 29 1 0
29 30 1 0
29 31 2 0
30 32 1 0
32 33 1 0
34 33 1 0
35 34 1 0
33 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 478.53Molecular Weight (Monoisotopic): 478.2129AlogP: 3.92#Rotatable Bonds: 9Polar Surface Area: 117.27Molecular Species: NEUTRALHBA: 7HBD: 4#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.16CX Basic pKa: 6.91CX LogP: 4.33CX LogD: 4.32Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.37Np Likeness Score: -1.05
References 1. Wrobleski ST, Moslin R, Lin S, Zhang Y, Spergel S, Kempson J, Tokarski JS, Strnad J, Zupa-Fernandez A, Cheng L, Shuster D, Gillooly K, Yang X, Heimrich E, McIntyre KW, Chaudhry C, Khan J, Ruzanov M, Tredup J, Mulligan D, Xie D, Sun H, Huang C, D'Arienzo C, Aranibar N, Chiney M, Chimalakonda A, Pitts WJ, Lombardo L, Carter PH, Burke JR, Weinstein DS.. (2019) Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165., 62 (20): [PMID:31318208 ] [10.1021/acs.jmedchem.9b00444 ]